Insulin without insurance in 2026: what cash prices actually look like

Five years ago, a single vial of brand-name insulin could run $300 cash. Today the picture is more complicated — and mostly better.

The federal Inflation Reduction Act capped Medicare insulin at $35/month per prescription. Manufacturers Lilly, Novo Nordisk, and Sanofi have voluntarily extended similar caps to commercial cash buyers. Biosimilars from Civica and others now sell vials in the $30–55 range.

But cash prices still vary 3–4x by pharmacy. We see Humalog vials anywhere from $35 (manufacturer assistance) to $148 (chain retail without coupon). Always price-check before pickup.

What to ask for: 'Lispro injection, U-100, biosimilar.' Those four words save people hundreds.